Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins

Oncogene volume 21, pages 8577–8583 (2002)Cite this article

Abstract

Shuttling hnRNPs control the fate of eukaryotic mRNAs throughout their journey from the active site of transcription to that of translation; thus, gain or loss of their function in hematopoietic cells might result in altered hematopoiesis and/or be associated with the process of leukemogenesis. In BCR/ABL-expressing cells, there is a marked increase in the protein levels FUS, hnRNP A1 and hnRNP E2, three RNA-binding proteins involved in the regulation of mRNA processing, nucleocytoplasmic export, and translation. Ectopic expression and/or inhibition of the activity of these RNA-binding proteins affects proliferation, survival, and differentiation of normal and BCR/ABL-expressing cells, suggesting that enhanced expression/activity of certain RNA-binding proteins plays an important, but as yet unrecognized, role in BCR/ABL leukemogenesis. The identification of the mRNA subsets associated with RNA-binding proteins upregulated in BCR/ABL-expressing cells should functionally link the process of leukemogenesis with alteration of mRNA metabolism.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  • Akamatzu W, Okano HJ, Osumi W, Inone T, Nakamura S, Sakakibara S, Miura M, Matsuo N, Darnell RB, Okano H . 1999 Proc. Natl. Acad. Sci. USA 96: 9885–9890

  • Aman P, Panagopoulos I, Lassen C, Fioretos T, Mencinger M, Toresson H, Hoglund M, Forster A, Rabbitts TH, Ron D, Mandahl N, Mitelman F . 1996 Genomics 37: 1–8

  • Bathia R, Wagner EA, McGlave PB, Verfaillie CM . 1994 J. Clin. Invest. 94: 384–391

  • Bedi A, Zehnbauer BA, Barber JP, Sharkis SJ, Jones RJ . 1994 Blood 83: 2038–2044

  • Biamonti G, Bassi MT, Cartegni L, Mechta F, Buvoli M, Cobianchi F, Riva S . 1993 J. Mol. Biol. 230: 77–89

  • Blanchette M, Chabot B . 1999 EMBO J. 18: 1939–1952

  • Brown V, Jin P, Ceman S, Darnell JC, O'Donnell WT, Tenenbaum SA, Jin X, Feng Y, Wilkinson KD, Keene JD, Darnell RB, Warren ST . 2001 Cell 107: 477–487

  • Burd CG, Dreyfuss G . 1994 EMBO J. 13: 1197–1204

  • Calvio C, Neubanci G, Mann M, Lamond AI . 1995 RNA 1: 724–728

  • Carlesso N, Frank DA, Griffin JD . 1996 J. Exp. Med. 183: 811–820

  • Chabot B, Blanchette M, La Pierre I, La Branche H . 1997 Mol. Cell. Biol. 19: 251–260

  • Chansky HA, Hu M, Hickstein DD, Yang L . 2001 Cancer Res. 61: 3586–3590

  • Cortez D, Kedlec L, Pendergast AM . 1995 Mol. Cell. Biol. 15: 5531–5541

  • Crozat A, Aman P, Mandahl N, Ron D . 1993 Nature 363: 640–643

  • Dai Z, Pendergast AM . 1995 Genes Dev. 9: 2569–2582

  • Dai Z, Quackenbusch RC, Courtney KD, Grove M, Cortez D, Reuther GW, Pendergast AM . 1998 Genes Dev. 12: 1415–1424

  • Daley GQ, Baltimore D . 1988 Proc. Natl. Acad. Sci. USA 85: 9312–9316

  • Daley GQ, Van Etten RA, Baltimore D . 1990 Science 247: 824–830

  • Darnell JC, Jensen KB, Jin P, Brown V, Warren ST, Darnell RB . 2001 Cell 107: 489–499

  • Deutsch E, Dugray A, Abdulkarim B, Marangoni E, Maggiorella L, Vaganay S, M'Kacher R, Rasy SD, Eschwege F, Vainchenker W, Turhan AG, Bourhis J . 2001 Blood 97: 2084–2090

  • Dreyfuss G, Matunis MJ, Pinol-Roma S, Burd CG . 1993 Annu. Rev. Biochem. 62: 289–321

  • Gishizky ML, Witte ON . 1992 Science 256: 836–839

  • Gouble A, Grazide S, Meggetto F, Mercier P, Delsol G, Morello D . 2002 Cancer Res. 62: 1489–1495

  • Hamasaki M, Kamma H, Wu W, Kaneko S, Fujiwara M, Satoh H, Haraoka S, Kikuchi M, Shirakusa T . 2001 Anticancer Res. 21: 979–984

  • Heisterkamp N, Jenster G, ten Hoeve J, Zovich D, Pattengale PK, Groffen J . 1990 Nature 344: 251–253

  • Hicks GG, Singh N, Nashabi A, Mai S, Bozek G, Klewes L, Arapovic D, White EK, Koury MJ, Oltz EM, Van Kaer L, Ruley HE . 2000 Nature Genet. 24: 175–180

  • Iervolino A, Santilli G, Trotta R, Guerzoni C, Cesi V, Bergamaschi A, Gambacorti-Passerini C, Calabretta B, Perrotti D . 2002 Mol. Cell. Biol. 22: 2255–2266

  • Ikeda S, Kishida S, Yarmamoto H, Murai H, Koama S, Kikuchi A . 1998 EMBO J. 17: 1371–1384

  • Izaurralde E, Jarnolowski A, Beisel C, Mattaj IW, Dreyfuss G, Fischer V . 1997 J. Cell. Biol. 137: 9155–9160

  • Jin P, Warren ST . 2000 Hum. Mol. Genet. 9: 901–908

  • Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M . 1993 Blood 82: 691–703

  • Kelleher MA, McLaughlin J, Witte ON, Rosenberg N . 1990 Proc. Natl. Acad. Sci. USA 87: 6649–6653

  • Laneuville P, Heisterkamp N, Groffen J . 1991 Oncogene 6: 275–282

  • Lian Z, Wang L, Yamaga S, Bonds W, Beazer-Barelay Y, Kluger Y, Gerstein M, Newburger PE, Berliner N, Weissman SM . 2001 Blood 98: 513–524

  • Majewski M, Nieborowska-Skorska M, Salomoni P, Slupianek A, Reiss K, Trotta R, Calabretta B, Skorski T . 1999 Cancer Res. 59: 2815–2820

  • Mandel M, Vadlamudi R, Nguyen D, Wang R-A, Costa L, Bagheri-Yarmand R, Mendelsohn J, Kumar R . 2001 J. Biol. Chem. 276: 9699–9704

  • McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR, Cotter TG . 1994 Blood 83: 1179–1187

  • McLaughlin J, Chianese E, Witte ON . 1987 Proc. Natl. Acad. Sci. USA 84: 6558–6562

  • Michael WM, Choi M, Dreyfuss G . 1995 Cell 83: 415–422

  • Mills KI, Walsh V, Gilkes AF, Sweeney MC, Mirza T, Woodgate LJ, Brown G, Burnett AK . 2000 Br. J. Haematol. 108: 316–322

  • Nakajima H, Ihle JM . 2001 Blood 98: 2077–2083

  • Nakanishi H, Brewer KA, Exton JH . 1993 J. Biol. Chem. 268: 13–19

  • Nieborowska-Skorska M, Wasik M, Slupianek A, Salomoni P, Kitamura T, Calabretta B, Skorski T . 1999 J. Exp. Med. 189: 1229–1242

  • Ostareck-Lederer A, Ostereck DH, Hentze MW . 1998 Trends. Biochem. Sci. 23: 409–411

  • Panagopoulos I, Mandahl N, Mitelman F, Aman P . 1995 Oncogene 11: 1133–1140

  • Perrotti D, Bonatti S, Trotta R, Martinez R, Skorski T, Salomoni P, Grassilli E, Iozzo RV, Cooper DR, Calabretta B . 1998 EMBO J. 17: 4442–4450

  • Perrotti D, Iervolino A, Cesi V, Cirinnà M, Lombardini S, Grassilli E, Bonatti S, Claudio PP, Calabretta B . 2000 Mol. Cell. Biol. 20: 6159–6169

  • Perrotti D, Cesi V, Trotta R, Guerzoni C, Santilli G, Campbell K, Iervolino A, Condorelli F, Gambacorti-Passerini C, Caligiuri MA, Calabretta B . 2002 Nature Genet. 30: 48–58

  • Pinol-Roma S, Dreyfuss G . 1991 Science 253: 312–314

  • Rabbitts TH, Forster A, Larson R, Nathan P . 1993 Nature Genet. 4: 175–181

  • Ron D . 1997 Curr. Top. Microbiol. Immunol. 220: 131–145

  • Sawyers CL . 1999 N. Engl. J. Med. 340: 1330–1340

  • Shi Y, Alin K, Goff SP . 1995 Genes Dev. 9: 2583–2597

  • Shimizu K, Ichikawa H, Tojo A, Kaneko Y, Mareki N, Hayashi Y, Ohira M, Asano S, Ohki M . 1993 Proc. Natl. Acad. Sci. USA 90: 10280–10284

  • Siomi MC, Eder PS, Kataoka N, Wan L, Liu Q, Dreyfuss G . 1997 J. Cell. Biol. 138: 1181–1192

  • Skorski T, Nieborowska-Skorska M, Wlodarski P, Zon G, Iozzo R, Calabretta B . 1996 Blood 88: 1005–1012

  • Skorski T, Wlodarski P, Daheron L, Salomoni P, Nieborowska-Skorska M, Majewski M, Wasik M, Calabretta B . 1998 Proc. Natl. Acad. Sci. USA 93: 11858–11862

  • Slupianek A, Schmutte C, Tombline G, Nieborowska-Skorska M, Hoser G, Nowicki MO, Pierce AJ, Fishel R, Skorski T . 2001 Mol. Cell. 8: 795–806

  • Sueoka E, Goto Y, Sueoka N, Kai Y, Kozu T, Fujcki H . 1999 Cancer Res. 59: 1404–1407

  • Svitkin YU, Ovchinmikov LP, Dreyfuss G, Sonenberg N . 1996 EMBO J. 15: 7147–7155

  • Tenen DG, Hromas R, Licht JD, Zhang DE . 1997 Blood 90: 489–519

  • Tenenbaum SA, Carson CC, Lager PJ, Keene JD . 2000 Proc. Natl. Acad. Sci. USA 97: 14085–14090

  • Ward AC, Loeb DM, Soede-Bobok AA, Touw IP, Friedman AD . 2000 ???? 14: 973–983

  • Winston JT, Strack P, Beer-Romero P, Chu CY, Elledge SJ . 1999 Genes Dev. 13: 270–283

  • Yang L, Embree LJ, Hickstein DD . 2000 Mol. Cell. Biol. 20: 3345–3354

  • Zinszner H, Sok J, Immanuel D, Yin Y, Ron D . 1997 J. Cell. Sci. 110: 1741–1748

  • Zhang DE, Zhang P, Wang ND, Hetherington CJ, Darlington GJ, Tenen DG . 1997 Proc. Natl. Acad. Sci. USA 94: 569–573

  • Zou X, Calame K . 1999 J. Biol. Chem. 274: 18141–18150

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology and Immunology, Thomas Jefferson University, Kimmel Cancer Institute, Philadelphia, 19107, PA, USA

    Danilo Perrotti & Bruno Calabretta

Authors
  1. Danilo Perrotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bruno Calabretta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bruno Calabretta.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Perrotti, D., Calabretta, B. Post-transcriptional mechanisms in BCR/ABL leukemogenesis: role of shuttling RNA-binding proteins. Oncogene 21, 8577–8583 (2002). https://doi.org/10.1038/sj.onc.1206085

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206085

Keywords

This article is cited by

Search

Advanced search

Quick links